Feb 04, 2021
Tyson Foods is piloting a new Matrix Medical Network (Matrix) program that assesses, addresses, verifies and monitors the effectiveness of the company’s efforts to protect workers from COVID-19.
More than a dozen Tyson Foods plant locations, including some of the company’s largest facilities, are participating. Six have already received safety verification and seven more are in the process of being assessed.
The Matrix Certification Program was developed in collaboration with Cleveland Clinic, one of the nation’s largest health systems, and is designed to help verify and monitor that businesses are taking appropriate measures to minimize the risk of COVID-19 transmission.
Tyson Food Inc. has new program to protect workers from COVID-19
VIDEO: Tyson Food Inc. has new program to protect workers from COVID-19 By Tamlyn Cochran | February 2, 2021 at 4:11 PM CST - Updated February 3 at 1:13 AM
AMARILLO, Texas (KFDA) - Tyson Foods, Inc. is piloting a new Matrix Medical Network program that assesses, addresses, verifies and monitors the effectiveness of the companyâs efforts to protect workers from COVID-19.
More than a dozen Tyson Food plant locations, including some of the companyâs largest facilities, are participating.
Six have already received safety verification and seven more are in the process of being assessed.
Share this article
SCOTTSDALE, Ariz., Feb. 3, 2021 /PRNewswire/ Matrix Medical Network
® (Matrix) today announced a collaboration with global biopharmaceutical company AstraZeneca to accelerate a clinical trial in the US for AZD7442, AstraZeneca s long-acting monoclonal antibody (LAAB) combination for the potential prevention of COVID-19. Matrix Clinical Solutions will meet eligible volunteers where they live and work with a fleet of Mobile Health Clinics and skilled clinicians, with a focus on populations more impacted by COVID-19.
Matrix Medical Network Mobile Health Clinic
Matrix is supporting the Phase III clinical trial called STORM CHASER, which will assess the safety and efficacy of AZD7442 for post-exposure prophylaxis in approximately 1,125 participants in the US and UK. Participants in this trial will include adults over 18 years of age following exposure to SARS-COV-2 and who are therefore at appreciable risk of developing COVID-19. The trial will include people liv
Vulnerable to the virus
February 2, 2021
The thousands of workers who pick, pack, and process our food have become eligible to receive the Covid-19 vaccine in many states. But they still face obstacles to actually getting the vaccine, as companies sort out their vaccination policies and advocates struggle to secure enough doses for a workforce that ranks among the most vulnerable to the coronavirus.
Labor organizations and the food industry spent months pushing for agricultural and food processing workers to be in early distribution phases of the Covid-19 vaccine. In December, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices recommended that agricultural workers be vaccinated in Phase 1b, and many states have followed suit.